Literature DB >> 9040484

Pharmacologic evidence for 5-HT1A receptors associated with human retinal pigment epithelial cells in culture.

M S Nash1, N N Osborne.   

Abstract

PURPOSE: The authors investigate the possible presence of 5-hydroxytryptamine (5-HT1) type serotonin receptors negatively coupled to adenylate cyclase activity in cultured human retinal pigment epithelial (RPE) cells.
METHODS: Adenylate cyclase activity was assessed by the determination of cellular adenosine 3':5' cyclic monophosphate (cAMP) levels and the effects of serotonin on both basal and forskolin-stimulated cAMP levels studied.
RESULTS: Serotonin at 100 microM had no effect on the basal levels of cAMP in cultured human RPE cells, but attenuated by 43.6% the stimulation in cAMP production induced by forskolin (5 microM). This effect was dose dependent for serotonin with half-maximal inhibition (EC50) occurring at approximately 1.5 x 10(-9) M. The 5-HT1 receptor agonist 8-hydroxy [2-di-n-propylamino] tetralin (8-OH DPAT), buspirone, 5-carboxyamidotryptamine, and RU24969 mimicked the inhibitory effect of serotonin in a dose-dependent manner. The actions of serotonin and 8-OH DPAT (10 microM) were dose-dependently attenuated by the serotonergic antagonists spiroxatrine, propranolol, and spiperone. Pretreatment of RPE cell cultures with pertussis toxin abolished the serotonin-induced reduction of forskolin-elevated cAMP levels. Stimulation of cAMP production by the beta-adrenoceptor agonist isoproterenol at 0.1 microM, but not at 10 microM or 100 microM, also was attenuated by serotonin (100 microM), whereas cAMP production induced by the adenosine receptor agonist 5'-[N-ethyl]-carboxamidoadenosine (NECA) at 1 microM, 10 microM, and 100 microM was unaffected. Serotonin and 8-OH DPAT dose-dependently inhibited isoproterenol-stimulated (0.1 microM) cAMP production with EC50 values of approximately 10 microM, and pertussis toxin pretreatment partially blocked these effects.
CONCLUSIONS: Cultured human RPE cells possess 5-HT1A receptors negatively coupled to cAMP production through a pertussis toxin-sensitive G protein. These receptors show differential effects on forskolin-, isoproterenol-, and NECA-stimulated cAMP production, which may reflect a unique spatial distribution of receptor proteins or the phenotypic heterogeneity of RPE cells that is the result of or that is preserved in culture.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9040484

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

1.  Glutamate acts at NMDA receptors on fresh bovine and on cultured human retinal pigment epithelial cells to trigger release of ATP.

Authors:  David Reigada; Wennan Lu; Claire H Mitchell
Journal:  J Physiol       Date:  2006-06-29       Impact factor: 5.182

2.  Oxytocin (OXT)-stimulated inhibition of Kir7.1 activity is through PIP2-dependent Ca2+ response of the oxytocin receptor in the retinal pigment epithelium in vitro.

Authors:  Nathaniel York; Patrick Halbach; Michelle A Chiu; Ian M Bird; De-Ann M Pillers; Bikash R Pattnaik
Journal:  Cell Signal       Date:  2017-06-08       Impact factor: 4.315

3.  Selective serotonin reuptake inhibitors: a review of its effects on intraocular pressure.

Authors:  Ciro Costagliola; Francesco Parmeggiani; Francesco Semeraro; Adolfo Sebastiani
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

4.  The 5HT1a receptor agonist 8-Oh DPAT induces protection from lipofuscin accumulation and oxidative stress in the retinal pigment epithelium.

Authors:  Prajitha Thampi; Haripriya Vittal Rao; Sayak K Mitter; Jun Cai; Haoyu Mao; Hong Li; Soojung Seo; Xiaoping Qi; Alfred S Lewin; Carl Romano; Michael E Boulton
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

5.  Chronic exercise improves repeated restraint stress-induced anxiety and depression through 5HT1A receptor and cAMP signaling in hippocampus.

Authors:  Mun Hee Kim; Yea Hyun Leem
Journal:  J Exerc Nutrition Biochem       Date:  2014-02-26

6.  Repurposing an orally available drug for the treatment of geographic atrophy.

Authors:  Chulbul M Ahmed; Manas R Biswal; Hong Li; Pingyang Han; Cristhian J Ildefonso; Alfred S Lewin
Journal:  Mol Vis       Date:  2016-04-02       Impact factor: 2.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.